Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.

Oniki K, Watanabe T, Kudo M, Izuka T, Ono T, Matsuda K, Sakamoto Y, Nagaoka K, Imafuku T, Ishima Y, Watanabe H, Maruyama T, Otake K, Ogata Y, Saruwatari J.

CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):384-393. doi: 10.1002/psp4.12292. Epub 2018 Mar 30.

2.

CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina.

Akasaka T, Sueta D, Arima Y, Tabata N, Takashio S, Izumiya Y, Yamamoto E, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Hokimoto S.

Int J Cardiol Heart Vasc. 2017 Apr 12;15:15-20. doi: 10.1016/j.ijcha.2017.03.001. eCollection 2017 Jun.

3.

Predictive factors for effectiveness and safety of enoxaparin for total knee arthroplasty in aged Japanese patients: a retrospective review.

Sonoda A, Kondo Y, Tsuneyoshi Y, Iwashita Y, Nakao S, Ishida K, Oniki K, Saruwatari J, Irie T, Ishitsuka Y.

J Pharm Health Care Sci. 2017 Jan 18;3:6. doi: 10.1186/s40780-017-0075-x. eCollection 2017.

4.

Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.

Tabata N, Sueta D, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Hokimoto S.

PLoS One. 2016 Nov 10;11(11):e0166240. doi: 10.1371/journal.pone.0166240. eCollection 2016.

5.

Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.

Akasaka T, Sueta D, Arima Y, Tabata N, Takashio S, Izumiya Y, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Matsui K, Hokimoto S.

Am J Physiol Heart Circ Physiol. 2016 Dec 1;311(6):H1409-H1415. doi: 10.1152/ajpheart.00473.2016. Epub 2016 Sep 23.

6.

The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.

Soraoka H, Oniki K, Matsuda K, Ono T, Taharazako K, Uchiyashiki Y, Kamihashi R, Kita A, Takashima A, Nakagawa K, Yasui-Furukori N, Kadowaki D, Miyata K, Saruwatari J.

Biol Pharm Bull. 2016;39(9):1468-74. doi: 10.1248/bpb.b16-00248.

7.

Common variants of HNF1A gene are associated with diabetic retinopathy and poor glycemic control in normal-weight Japanese subjects with type 2 diabetes mellitus.

Morita K, Saruwatari J, Tanaka T, Oniki K, Kajiwara A, Miyazaki H, Yoshida A, Jinnouchi H, Nakagawa K.

J Diabetes Complications. 2017 Feb;31(2):483-488. doi: 10.1016/j.jdiacomp.2016.06.007. Epub 2016 Jun 14.

PMID:
27445006
8.

Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes.

Kajiwara A, Kita A, Saruwatari J, Miyazaki H, Kawata Y, Morita K, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.

J Diabetes Res. 2016;2016:4626382. doi: 10.1155/2016/4626382. Epub 2016 May 9.

9.

The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease.

Oniki K, Morita K, Watanabe T, Kajiwara A, Otake K, Nakagawa K, Sasaki Y, Ogata Y, Saruwatari J.

Nutr Diabetes. 2016 May 23;6:e210. doi: 10.1038/nutd.2016.17.

10.

Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.

Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N.

Pharmacogenet Genomics. 2016 Sep;26(9):403-13. doi: 10.1097/FPC.0000000000000228.

PMID:
27187662
11.

Helicobacter Pylori-seropositivity along with genetic and environmental factors predicts clinical outcome after acute coronary syndrome.

Tabata N, Hokimoto S, Akasaka T, Sueta D, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogawa H.

Int J Cardiol. 2016 Jun 1;212:54-6. doi: 10.1016/j.ijcard.2016.03.034. Epub 2016 Mar 16. No abstract available.

PMID:
27019048
12.

Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.

Oniki K, Kamihashi R, Tomita T, Ishioka M, Yoshimori Y, Osaki N, Tsuchimine S, Sugawara N, Kajiwara A, Morita K, Miyata K, Otake K, Nakagawa K, Ogata Y, Saruwatari J, Yasui-Furukori N.

Psychiatry Res. 2016 May 30;239:190-5. doi: 10.1016/j.psychres.2016.03.025. Epub 2016 Mar 16.

PMID:
27010189
13.

Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.

Akasaka T, Hokimoto S, Sueta D, Tabata N, Sakamoto K, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Ogawa H.

Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1494-500. doi: 10.1152/ajpheart.00911.2015. Epub 2016 Mar 18.

14.

The Influence of Phacoemulsification on Surgical Outcomes of Trabeculectomy with Mitomycin-C for Uveitic Glaucoma.

Nishizawa A, Inoue T, Ohira S, Takahashi E, Saruwatari J, Iwao K, Tanihara H.

PLoS One. 2016 Mar 18;11(3):e0151947. doi: 10.1371/journal.pone.0151947. eCollection 2016.

15.

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.

Nakashima H, Oniki K, Nishimura M, Ogusu N, Shimomasuda M, Ono T, Matsuda K, Yasui-Furukori N, Nakagawa K, Ishitsu T, Saruwatari J.

PLoS One. 2015 Oct 20;10(10):e0141266. doi: 10.1371/journal.pone.0141266. eCollection 2015.

16.

Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus.

Kajiwara A, Kita A, Saruwatari J, Oniki K, Morita K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.

Clin Drug Investig. 2015 Sep;35(9):593-600. doi: 10.1007/s40261-015-0314-6.

PMID:
26293520
17.

Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.

Noai M, Soraoka H, Kajiwara A, Tanamachi Y, Oniki K, Nakagawa K, Ishitsu T, Saruwatari J.

Acta Neurol Scand. 2016 Mar;133(3):216-23. doi: 10.1111/ane.12473. Epub 2015 Jul 30.

PMID:
26223287
18.

Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Oniki K, Saruwatari J, Izuka T, Kajiwara A, Morita K, Sakata M, Otake K, Ogata Y, Nakagawa K.

PLoS One. 2015 Jul 22;10(7):e0132640. doi: 10.1371/journal.pone.0132640. eCollection 2015.

19.

A functional variant in the γ-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers.

Morita K, Masuda N, Tanaka T, Saruwatari J, Oniki K, Kajiwara A, Otake K, Ogata Y, Nakagawa K.

Clin Chem Lab Med. 2015 Nov;53(12):e339-41. doi: 10.1515/cclm-2015-0331. No abstract available.

PMID:
26083269
20.

Association between the aldehyde dehydrogenase 2*2 allele and smoking-related chronic airway obstruction in a Japanese general population: a pilot study.

Morita K, Masuda N, Oniki K, Saruwatari J, Kajiwara A, Otake K, Ogata Y, Nakagawa K.

Toxicol Lett. 2015 Jul 16;236(2):117-22. doi: 10.1016/j.toxlet.2015.05.007. Epub 2015 May 12.

PMID:
25978981
21.

ABO Blood Type and Personality Traits in Healthy Japanese Subjects.

Tsuchimine S, Saruwatari J, Kaneda A, Yasui-Furukori N.

PLoS One. 2015 May 15;10(5):e0126983. doi: 10.1371/journal.pone.0126983. eCollection 2015.

22.

Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy.

Jinnouchi H, Morita K, Tanaka T, Kajiwara A, Kawata Y, Oniki K, Saruwatari J, Nakagawa K, Otake K, Ogata Y, Yoshida A, Hokimoto S, Ogawa H.

Cardiovasc Diabetol. 2015 May 8;14:49. doi: 10.1186/s12933-015-0212-5.

23.

Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy.

Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K.

Neuropsychiatr Dis Treat. 2015 Apr 7;11:1007-14. doi: 10.2147/NDT.S80898. eCollection 2015.

24.

Safety analysis of zolpidem in elderly subjects 80 years of age or older: adverse event monitoring in Japanese subjects.

Kajiwara A, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Morita K, Oniki K, Saruwatari J, Nakagawa K.

Aging Ment Health. 2016;20(6):611-5. doi: 10.1080/13607863.2015.1031640. Epub 2015 Apr 14.

PMID:
25871951
25.

A case of repetitive and simultaneous stent thromboses.

Sueta D, Hokimoto S, Enomoto K, Ono T, Tabata T, Kajiwara I, Kaikita K, Saruwatari J, Oniki K, Nakagawa K, Ogawa H.

Int J Cardiol. 2015;186:210-2. doi: 10.1016/j.ijcard.2015.03.217. Epub 2015 Mar 18. No abstract available.

PMID:
25828117
26.

Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients.

Morita K, Miyazaki H, Saruwatari J, Oniki K, Kumagae N, Tanaka T, Kajiwara A, Otake K, Ogata Y, Arima Y, Hokimoto S, Ogawa H, Nakagawa K.

Toxicol Lett. 2015 Jan 5;232(1):221-5. doi: 10.1016/j.toxlet.2014.11.014. Epub 2014 Nov 15.

PMID:
25448285
27.

Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis.

Ogusu N, Saruwatari J, Nakashima H, Noai M, Nishimura M, Deguchi M, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagaswa K.

PLoS One. 2014 Nov 5;9(11):e111066. doi: 10.1371/journal.pone.0111066. eCollection 2014.

28.

Associations between the common HNF1A gene variant p.I27L (rs1169288) and risk of type 2 diabetes mellitus are influenced by weight.

Morita K, Saruwatari J, Tanaka T, Oniki K, Kajiwara A, Otake K, Ogata Y, Nakagawa K.

Diabetes Metab. 2015 Feb;41(1):91-4. doi: 10.1016/j.diabet.2014.04.009. Epub 2014 Jun 2.

PMID:
24933231
29.

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders.

Saruwatari J, Nakashima H, Tsuchimine S, Nishimura M, Ogusu N, Yasui-Furukori N.

Pharmgenomics Pers Med. 2014 May 28;7:121-7. doi: 10.2147/PGPM.S60747. eCollection 2014.

30.

Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patients.

Kajiwara A, Saruwatari J, Kita A, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.

Clin Drug Investig. 2014 Jun;34(6):431-5. doi: 10.1007/s40261-014-0191-4.

PMID:
24728902
31.

Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM.

Hirata K, Saruwatari J, Enoki Y, Iwata K, Urata Y, Aizawa K, Ueda K, Shirouzono T, Imamura M, Moriuchi H, Ishima Y, Kadowaki D, Watanabe H, Hirata S, Maruyama T, Fukunaga E.

Ther Drug Monit. 2014 Oct;36(5):553-5. doi: 10.1097/FTD.0000000000000067.

PMID:
24632808
32.

ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.

Sha'ari HM, Haerian BS, Baum L, Saruwatari J, Tan HJ, Rafia MH, Raymond AA, Kwan P, Ishitsu T, Nakagawa K, Lim KS, Mohamed Z.

Pharmacogenomics. 2014 Mar;15(4):459-66. doi: 10.2217/pgs.13.239.

PMID:
24624913
33.

Effects of Seijo-bofu-to, a traditional Japanese herbal medicine containing furanocoumarin derivatives, on the drug-metabolizing enzyme activities in healthy male volunteers.

Saruwatari J, Takashima A, Yoshida K, Soraoka H, Ding TB, Uchiyashiki Y, Tsuda Y, Imamura M, Oniki K, Miyata K, Nakagawa K.

Basic Clin Pharmacol Toxicol. 2014 Oct;115(4):360-5. doi: 10.1111/bcpt.12224. Epub 2014 Mar 21.

34.

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine.

Tsuda Y, Saruwatari J, Yasui-Furukori N.

BMJ Open. 2014 Mar 4;4(3):e004216. doi: 10.1136/bmjopen-2013-004216.

35.

Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study.

Kajiwara A, Miyagawa H, Saruwatari J, Kita A, Sakata M, Kawata Y, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.

Diabetes Res Clin Pract. 2014 Mar;103(3):e7-10. doi: 10.1016/j.diabres.2013.12.043. Epub 2014 Jan 6.

PMID:
24503044
36.

Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction.

Saruwatari J, Yoshida S, Tsuda Y, Okada Y, Ogusu N, Yoshida K, Oniki K, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.

Pharmacogenet Genomics. 2014 Mar;24(3):162-71. doi: 10.1097/FPC.0000000000000030.

PMID:
24384557
37.

Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsy.

Saruwatari J, Ogusu N, Shimomasuda M, Nakashima H, Seo T, Tanikawa K, Tsuda Y, Nishimura M, Nagata R, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.

Ther Drug Monit. 2014 Jun;36(3):302-9. doi: 10.1097/FTD.0000000000000015.

PMID:
24345815
38.

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia.

Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K.

Neuropsychiatr Dis Treat. 2013;9:1683-98. doi: 10.2147/NDT.S52585. Epub 2013 Nov 1.

39.

Absence of gargling affects topical adverse symptoms caused by inhaled corticosteroids in females.

Kajiwara A, Kita A, Saruwatari J, Morita K, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.

J Asthma. 2014 Mar;51(2):221-4. doi: 10.3109/02770903.2013.857683. Epub 2013 Nov 19.

PMID:
24147582
40.

Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy: a retrospective longitudinal study in Japanese patients with type 2 diabetes.

Kajiwara A, Saruwatari J, Kita A, Kamihashi R, Miyagawa H, Sakata M, Noai M, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.

Pharmacogenet Genomics. 2013 Dec;23(12):717-20. doi: 10.1097/FPC.0000000000000009.

PMID:
24113215
41.

Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study.

Morita K, Oniki K, Miyazaki H, Saruwatari J, Ogata Y, Mizobe M, Yamamuro M, Hokimoto S, Ogawa H, Nakagawa K.

J Hum Hypertens. 2014 Apr;28(4):279-81. doi: 10.1038/jhh.2013.90. Epub 2013 Sep 26.

PMID:
24067347
42.

Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus.

Morita K, Saruwatari J, Miyagawa H, Uchiyashiki Y, Oniki K, Sakata M, Kajiwara A, Yoshida A, Jinnouchi H, Nakagawa K.

Cardiovasc Diabetol. 2013 Sep 13;12:132. doi: 10.1186/1475-2840-12-132.

43.

Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture.

Kajiwara A, Saruwatari J, Sakata M, Morita K, Kita A, Oniki K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.

Drug Saf. 2013 Oct;36(10):981-7. doi: 10.1007/s40264-013-0077-z.

PMID:
23743694
44.

Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease.

Oniki K, Hori M, Saruwatari J, Morita K, Kajiwara A, Sakata M, Mihara S, Ogata Y, Nakagawa K.

Toxicol Lett. 2013 Jul 4;220(2):143-9. doi: 10.1016/j.toxlet.2013.04.019. Epub 2013 Apr 30.

PMID:
23643483
45.

Clinical features associated with a rapid decline in renal function among Japanese patients with type 2 diabetes mellitus: microscopic hematuria coexisting with diabetic retinopathy.

Sakata M, Oniki K, Kita A, Kajiwara A, Uchiyashiki Y, Saruwatari J, Yoshida A, Jinnouchi H, Nakagawa K.

Diabetes Res Clin Pract. 2013 May;100(2):e39-41. doi: 10.1016/j.diabres.2013.01.031. Epub 2013 Feb 19.

PMID:
23433540
46.

The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption.

Nakagawa T, Kajiwara A, Saruwatari J, Hamamoto A, Kaku W, Oniki K, Mihara S, Ogata Y, Nakagawa K.

Pharmacogenet Genomics. 2013 Jan;23(1):34-7. doi: 10.1097/FPC.0b013e32835b1707.

PMID:
23111423
47.

SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.

Haerian BS, Baum L, Tan HJ, Kwan P, Raymond AA, Saruwatari J, Nakagawa K, Mohamed Z.

Pharmacogenomics. 2012 Oct;13(13):1477-85. doi: 10.2217/pgs.12.127.

PMID:
23057548
48.

A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.

Saruwatari J, Takaishi C, Yoshida K, Takashima A, Fujimura Y, Umemoto Y, Abe T, Kitamado M, Shimomasuda M, Muramoto Y, Nakagawa K.

J Pharm Pharmacol. 2012 May;64(5):670-6. doi: 10.1111/j.2042-7158.2011.01443.x. Epub 2012 Feb 7.

PMID:
22471362
49.

Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.

Saruwatari J, Yasui-Furukori N, Niioka T, Akamine Y, Takashima A, Kaneko S, Uno T.

J Clin Psychopharmacol. 2012 Apr;32(2):195-9. doi: 10.1097/JCP.0b013e318248ddb9.

PMID:
22367658
50.

Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases.

Saruwatari J, Deguchi M, Yoshimori Y, Noai M, Yoshida S, Ogusu N, Oniki K, Yoshida S, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.

Epilepsy Res. 2012 Mar;99(1-2):183-6. doi: 10.1016/j.eplepsyres.2011.10.033. Epub 2011 Nov 25.

PMID:
22119635

Supplemental Content

Loading ...
Support Center